Novel discovery improves profiling of acute myeloid leukemia patients for targeted therapies

Posted by on July 8, 2016 12:19 pm
Categories: health

Researchers have identified a set of genes, including DNMT3A, that could potentially be used to predict clinical outcomes of patients who suffer from a type of Acute Myeloid Leukemia (AML) associated with an FLT3 internal tandem duplication (FLT3-ITD) mutation.

Leave a Reply

Your email address will not be published. Required fields are marked *